Savara Announces Expanded Access Program (Eap) for Molgramostim Inhalation Solution (Molgramostim) for Patients With Autoimmune Pulmonary Alveolar Proteinosis (Apap)
Savara宣佈爲自身免疫性肺泡蛋白沉積症(APAP)患者提供莫克的單克隆噴霧解決方案(Molgramostim)的擴大使用計劃(EAP)
Savara Announces Expanded Access Program (Eap) for Molgramostim Inhalation Solution (Molgramostim) for Patients With Autoimmune Pulmonary Alveolar Proteinosis (Apap)
Savara宣佈爲自身免疫性肺泡蛋白沉積症(APAP)患者提供莫克的單克隆噴霧解決方案(Molgramostim)的擴大使用計劃(EAP)
譯文內容由第三人軟體翻譯。